These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 18666366)

  • 1. Clinical experience with the use of angiotensin receptor blockers in patients with cardiovascular, cerebrovascular and renal diseases.
    Chrysant SG
    Curr Clin Pharmacol; 2006 May; 1(2):139-46. PubMed ID: 18666366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin receptor blocker selectivity at the AT1- and AT2-receptors: conceptual and clinical effects.
    Unger T; Sandmann S
    J Renin Angiotensin Aldosterone Syst; 2000 Jun; 1(2 Suppl):S6-9. PubMed ID: 17199211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathophysiologic role of the brain renin-angiotensin system in stroke protection: clinical implications.
    Chrysant SG
    J Clin Hypertens (Greenwich); 2007 Jun; 9(6):454-9. PubMed ID: 17541331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms for the clinical benefits of angiotensin II receptor blockers.
    Schmieder RE
    Am J Hypertens; 2005 May; 18(5 Pt 1):720-30. PubMed ID: 15882557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin receptor blockers: current status and future prospects.
    Ram CV
    Am J Med; 2008 Aug; 121(8):656-63. PubMed ID: 18691475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pleiotropic effects of angiotensin receptor blockers.
    Chrysant SG; Chrysant GS
    J Clin Hypertens (Greenwich); 2006 Apr; 8(4):261-8. PubMed ID: 16596029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacokinetics of angiotensin II (AT1) receptor blockers in hypertension.
    Israili ZH
    J Hum Hypertens; 2000 Apr; 14 Suppl 1():S73-86. PubMed ID: 10854085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candesartan: widening indications for this angiotensin II receptor blocker?
    Mendis B; Page SR
    Expert Opin Pharmacother; 2009 Aug; 10(12):1995-2007. PubMed ID: 19563275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-receptor blockers: benefits beyond lowering blood pressure.
    Silverstein RL; Ram CV
    Cleve Clin J Med; 2005 Sep; 72(9):825-32. PubMed ID: 16193831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral ischemia induced inflammatory response and altered glutaminergic function mediated through brain AT
    Justin A; Divakar S; Ramanathan M
    Biomed Pharmacother; 2018 Jun; 102():947-958. PubMed ID: 29710550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing angiotensin II receptor blockers on benefits beyond blood pressure.
    Siragy HM
    Adv Ther; 2010 May; 27(5):257-84. PubMed ID: 20524096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II type 1 receptor blockade: high hopes sent back to reality?
    Grothusen A; Divchev D; Luchtefeld M; Schieffer B
    Minerva Cardioangiol; 2009 Dec; 57(6):773-85. PubMed ID: 19942847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience with angiotensin receptor blockers with particular reference to valsartan.
    Chrysant SG; Chrysant GS
    J Clin Hypertens (Greenwich); 2004 Aug; 6(8):445-51. PubMed ID: 15308883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative assessment of angiotensin receptor blockers in different clinical settings.
    Verdecchia P; Angeli F; Repaci S; Mazzotta G; Gentile G; Reboldi G
    Vasc Health Risk Manag; 2009; 5():939-48. PubMed ID: 19997575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.
    Thomas GN; Chan P; Tomlinson B
    Drugs Aging; 2006; 23(2):131-55. PubMed ID: 16536636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II antagonists--therapeutic benefits spanning the cardiovascular disease continuum from hypertension to heart failure and diabetic nephropathy.
    Ribeiro AB
    Curr Med Res Opin; 2006 Jan; 22(1):1-16. PubMed ID: 16393425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complications of hypertension and the role of angiotensin receptor blockers in hypertension trials.
    Flaa A; Aksnes TA; Strand A; Kjeldsen SE
    Expert Rev Cardiovasc Ther; 2007 May; 5(3):451-61. PubMed ID: 17489670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The management of hypertension with angiotensin receptor blockers in special populations.
    Ferdinand KC; Taylor C
    Clin Cornerstone; 2009; 9 Suppl 3():S5-17. PubMed ID: 19409356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive, cardiovascular, and pleiotropic effects of angiotensin-receptor blockers.
    Sierra C; de la Sierra A
    Curr Opin Nephrol Hypertens; 2005 Sep; 14(5):435-41. PubMed ID: 16046901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin receptor blockers and cerebral protection in stroke.
    Thöne-Reineke C; Steckelings UM; Unger T
    J Hypertens Suppl; 2006 Mar; 24(1):S115-21. PubMed ID: 16601564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.